PTGS2 and prostate carcinoma: Increased expression of cyclooxygenase-2 (COX-2), an enzyme that catalyzes the synthesis of prostanoids such as prostaglandin E2 (PGE2) from arachidonic acid [4-6], was identified as an independent predictor of prostate cancer progression [7].